INR reporting in Canadian medical laboratories: An update

American Journal of Clinical Pathology

Volumn 109, Issue 5, 1998, Pages 589-594

  Brigden, Malcolm L ^a   Johnston, Marilyn J ^b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulation; Anticoagulation monitoring; Anticoagulation quality control; INR; International normalized ration; International Sensitivity Index; ISI; Thromboplastin; Warfarin therapy

Indexed keywords

ANTICOAGULANT AGENT; THROMBOPLASTIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CANADA; CLINICAL LABORATORY; GOOD LABORATORY PRACTICE; HEART VALVE REPLACEMENT; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; THROMBOEMBOLISM;

EID: 0031897315     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.5.589     Document Type: Article

References (25)

1. Andrew M, Brigden M, Bormanis J, et al. INR reporting in Canadian medical laboratories. Am J Hematol. 1995;48:237-238.
2. Ts'ao C, Neofotistos D. The use and limitations of the INR system. Am J Hematol. 1994;47:21-26.
3. Hirsh J, Poller L. The international normalized ratio: a guide to understanding and correcting its problems. Arch Intern Med. 1994;282-288.
4. Koepke JA. Is the international normalized ratio also 'valid' for prothrombin times measured in patients not receiving oral anticoagulants? Arch Pathol Lab Med. 1994;118:1181-1182.
5. Preston FE. Quality control and oral anticoagulation. Thromb Haemost. 1995;74:515-520.
6. Ng VL, Levin J, Corash L, et al. Failure of the international normalized ratio to generate consistent results within a local medical community. Am J Clin Pathol 1993;99:689-694.
7. Gaff SB, Rodgers GM. Laboratory monitoring of warfarin therapy in Utah. Am J Hematol. 1994;45:85-87.
8. Ray MJ, Smith IR. The dependence of the International Sensitivity Index on the coagulometer used to perform the prothrombin time. Thromb Haemost. 1990;63:424-429.
9. Becker DM, Humphries JE, Walker FB, et al. Standardizing the prothrombin time: calibrating coagulation instruments as well as thromboplastin. Arch Pathol Lab Med. 1993;117:605.
10. Hirsh J, Dalen J, Deykin D, et al. Oral anticoagulants. Chest. 1995;108:231S-246S.
11. Brigden M. Oral anticoagulant therapy: practical aspects of management. Postgrad Med. 1996;99:81-101.
12. Andrews TC, Peterson DW, Doeppenschmidt D, et al. Complications of warfarin therapy monitored by the international normalized ratio versus the prothrombin time ratio. Clin Cardiol. 1995;18:80-82.
13. Palareti G, Coccheri S, Poggi M, et al. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results: the Bologna oral anticoagulant control exercise. Thromb Haemost. 1987;58:905-910.
14. Sage-El A, Burns E, Wenz B. The unwarranted use of replicate analysis in routine coagulation studies. Am J Clin Pathol. 1985;83:81-83.
15. Kramer G, Bradlow BA. An analysis of duplicate testing of prothrombin time and activated partial thromboplastin time assays. Am J Clin Pathol. 1991;95:77-81.
16. National Committee for Clinical Laboratory Standards. Collection, Transport and Preparation of Blood Specimens for Coagulation Testing and Performance of Coagulation Assays. H21-A2. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1991.
17. Bussey HI, Force RW, Bianco TM, et al. Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy. Arch Intern Med. 1992;152:278-282.
18. Le DT, Weibert RT, Seville BK, et al. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods. Ann Intern Med. 1994;120:552-558.
19. Poller L, Triplett DA, Hirsch J, et al. The value of plasma calibrants in correcting coagulometer effects on international normalized ratios: an international multicenter study. Am J Clin Pathol. 1995;103:358-365.
20. Critchfield GC, Bennett ST. The influence of the reference mean prothrombin time on the international normalized ratio. Am J Clin Pathol. 1994;102:806-811.
21. Cannegietter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves: optimal oral anticoagulation for patients with mechanical heart valves. N Engl J Med. 1995;333:11-17.
22. The European Atrial Fibrillation Trial Study Group. Optimal anticoagulation for nonrheumatic atrial fibrillation. N Engl J Med. 1995;333:5-10.
23. Phillips WS, Preston FE, Brown M, et al. Over-anticoagulation, risk of haemorrhage and mortality. Thromb Haemost. 1995;73:1118. Abstract 836.
24. Kovacs MJ, Wong A, MacKinnon K, et al. Assessment of the validity of the INR system for patients with liver impairment. Thromb Haemost. 1994;71:727-730.
25. McKernan A, Thomson JM, Poller L. The reliability of the international normalized ratio during short-term oral anticoagulant treatment. Clin Lab Haematol. 1988;10:63-71.